Study of the Efficacy and Safety of Intravenous Pamrevlumab, in Hospitalized Participants With Acute COVID-19 Disease

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
This study evaluates the efficacy and safety of intravenous (IV) infusions of pamrevlumab when compared with placebo in participants who are hospitalized with acute COVID-19 disease.
Epistemonikos ID: 3b58efb56057b9ff26e719688d239ece32b785cb
First added on: Jun 17, 2020